RNAP targeting metalloenzyme inhibitors (Forge)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRNAP targeting metalloenzyme inhibitors (Forge)
Drug Alias NameRNA polymerase inhibitors (Forge Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBlacksmith Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBlacksmith Medicines Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A